We are live on ! Find out more
Stanley Druckenmiller

Stanley Druckenmiller Duquesne Family Office

AUM $3.38B
1-Year Est. Return 61.92%
 

Stanley Druckenmiller is the founder of Duquesne Family Office and one of the most closely watched macro investors of his generation. He first became widely known as lead portfolio manager of the Quantum Fund alongside George Soros, including during the famous 1992 bet against the British pound. After returning outside capital, he has continued to invest with a flexible, top-down approach that blends macroeconomic views with concentrated equity and commodity positions.

This Fund
S&P 500
This Quarter Est. Return
+3.34%
1 Year Est. Return
+61.92%
3 Year Est. Return
+280.57%
5 Year Est. Return
+393.65%
10 Year Est. Return
+4,147.23%
AUM
$1.48B
AUM Growth
+$697M
Cap. Flow
+$698M
Cap. Flow %
47.06%
Top 10 Hldgs %
69.57%
Holding
46
New
18
Increased
1
Reduced
6
Closed
17

Top Sells

Rank Stock Value
1
BIIB icon
Biogen
BIIB
+$73.9M
2
TEVA icon
Teva Pharmaceuticals
TEVA
+$49.2M
3
ILMN icon
Illumina
ILMN
+$40.9M
4
CTSH icon
Cognizant
CTSH
+$30.8M
5
INFY icon
Infosys
INFY
+$26.5M

Sector Composition

Rank Sector Weight
1 Financials 23.39%
2 Materials 19.25%
3 Communication Services 10.82%
4 Technology 8.51%
5 Energy 8.3%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
EMN icon
26
Eastman Chemical
EMN
$8.4B
$15.2M 1.03%
+186,000
New +$14.3M
TCOM icon
27
Trip.com Group
TCOM
$29.7B
$14.6M 0.99%
+402,800
New +$14.1M
CTSH icon
28
Cognizant
CTSH
$24.7B
$14.5M 0.97%
236,800
-490,100
-67% -$30.8M
NBL
29
DELISTED
Noble Energy, Inc.
NBL
$13.5M 0.91%
315,200
-306,100
-49% -$14.4M
BIDU icon
30
Baidu
BIDU
$38.2B
-86,200
Closed -$18M
BIIB icon
31
Biogen
BIIB
$30.7B
-175,000
Closed -$73.9M
BLUE
32
DELISTED
bluebird bio
BLUE
-14,211
Closed -$22.2M
BMA icon
33
Banco Macro
BMA
$5.89B
-110,100
Closed -$6.3M
EXPE icon
34
Expedia Group
EXPE
$37.1B
-160,000
Closed -$15.1M
INFY icon
35
Infosys
INFY
$50.1B
-3,026,000
Closed -$26.5M
IRS
36
IRSA Inversiones y Representaciones
IRS
$1.27B
-41,841
Closed -$794K
LNG icon
37
Cheniere Energy
LNG
$54.1B
-258,700
Closed -$20M
MGNX icon
38
MacroGenics
MGNX
$243M
-472,500
Closed -$14.8M
NKTR icon
39
Nektar Therapeutics
NKTR
$2.46B
-43,667
Closed -$7.21M
PAM icon
40
Pampa Energía
PAM
$4.57B
-214,899
Closed -$3.8M
QSR icon
41
Restaurant Brands International
QSR
$25.6B
-514,000
Closed -$19.7M
TEO icon
42
Telecom Argentina
TEO
$5.89B
-248,000
Closed -$5.63M
TEVA icon
43
Teva Pharmaceuticals
TEVA
$39.8B
-790,500
Closed -$49.2M
YPF icon
44
YPF
YPF
$19.4B
-698,300
Closed -$19.2M
MFRM
45
DELISTED
MATTRESS FIRM HLDG CORP COM STK (DE)
MFRM
-86,900
Closed -$6.05M
CELG
46
DELISTED
Celgene Corp
CELG
-195,975
Closed -$22.6M

Similar funds

Stanley Druckenmiller's Q2 2015 Portfolio in Review

As of Q2 2015, Stanley Druckenmiller held 46 positions worth $1.48B, up 89% from $787M the previous quarter. Its ten largest holdings account for 70% of the portfolio.

Stanley Druckenmiller deployed $698M of net new capital in Q2 2015, opening 18 new positions and adding to 1 existing holding. Its largest new stake was SPDR Gold Trust: 2,880,000 shares worth $324M.

By sector, the portfolio is most concentrated in Financials at 23% of assets, up from 8.3% a quarter earlier, followed by Materials and Communication Services.

On the sell side, the largest reduction was Illumina, an estimated $40.9M trimmed.

  • Stanley Druckenmiller's largest Q2 2015 buy was SPDR Gold Trust: 2,880,000 shares worth $324M.
  • Stanley Druckenmiller added most to Meta Platforms (Facebook) in Q2 2015, an estimated $132M increase.
  • Stanley Druckenmiller's biggest Q2 2015 reduction was Illumina, cutting an estimated $40.9M.
  • Stanley Druckenmiller fully exited Biogen in Q2 2015, selling an estimated $73.9M.
  • Stanley Druckenmiller's ten largest holdings make up 70% of its $1.48B portfolio in Q2 2015.
  • Stanley Druckenmiller opened 18 new positions and closed 17 in Q2 2015.
  • Stanley Druckenmiller's portfolio value rose 89% quarter-over-quarter to $1.48B.

Based on Duquesne Family Office's 13F filing for Q2 2015, filed 14 Aug 2015.